Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

Overview of attention for article published in Cancer Immunology, Immunotherapy, October 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 1 X post from an account with 0 followers.

6 of 11 advanced ovarian cancer patients disease free at 36 months after dendritic cell vaccination with hTERT http://t.co/4wuxaZU0

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.